小儿黄龙颗粒经菌群-肠-脑轴改善注意缺陷多动障碍
本研究在大鼠ADHD模型中比较小儿黄龙颗粒胃释、肠释和结肠释制剂的疗效与机制。结肠释制剂行为改善最优,作用与恢复肠道菌群稳态、减轻炎症、修复肠与血脑屏障及纠正氨基酸代谢紊乱相关,粪菌移植验证了菌群的中介作用。
要点
- 小儿黄龙颗粒三种释药制剂均改善ADHD样行为与神经递质功能障碍。
- 结肠释制剂干预效果优于胃释和肠释制剂。
- 疗效经菌群-肠-脑轴介导,粪菌移植实验支持菌群的关键作用。
核心结论
- 小儿黄龙颗粒通过改善菌群-肠-脑轴和纠正氨基酸代谢紊乱发挥抗ADHD作用。
研究设计与样本
- 研究在ADHD模型大鼠中比较小儿黄龙颗粒胃释(WR_HL)、肠释(CR_HL)和结肠释(JCR_HL)制剂的疗效与机制。
- 采用行为学评估、酶联免疫吸附测定和Western-blot分析评价治疗效果。
- 采用16S核糖体RNA测序及非靶向和靶向代谢组学分析菌群-肠-脑轴。
- 采用粪菌移植(FMT)验证肠道菌群的因果作用。
主要发现
- WR_HL、CR_HL和JCR_HL均改善ADHD样行为和神经传递功能障碍,其中JCR_HL干预效果优于WR_HL和CR_HL。
- 治疗作用与恢复肠道微生物稳态、减轻炎症级联反应及修复受损肠道屏障和血脑屏障相关。
- 干预纠正了氨基酸代谢、神经递质调节和短链脂肪酸产生方面的系统性代谢失衡。
- FMT实验证实微生物调节介导了小儿黄龙颗粒的行为和微生物调节效应。
临床怎么用
- 提示小儿黄龙颗粒治疗ADHD的效应可能依赖菌群-肠-脑轴,结肠释制剂在模型中效果更优。
- 临床关注ADHD患者肠道菌群与氨基酸代谢状态可能有助于理解中药疗效。
局限性
- 研究基于ADHD模型大鼠,结论外推至临床患者需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recently, research interest in attention deficit hyperactivity disorder (ADHD) has grown significantly, driven by its increasing incidence and substantial societal impact. Among the various pathogenic mechanisms under investigation, the microbiota-gut-brain axis has emerged as a crucial area of focus. In the context of ADHD treatment, Xiaoer Huanglong Pellets (XRHLP), a traditional Chinese herbal formulation, have demonstrated therapeutic efficacy, although the underlying mechanisms remain partially understood. PURPOSE: This study aimed to analyze and compare the therapeutic effects and underlying mechanisms of XRHLP, including gastric release (WR_HL), enteric release (CR_HL), and colon release (JCR_HL) pellets, for ADHD treatment. METHODS: This study employed a multi-modal approach to investigate the effects of XRHLP on ADHD. Behavioral assessments combined with Enzyme-linked immunosorbent assay and Western-blot analyses were conducted to evaluate the therapeutic outcomes in model rats with ADHD. Comprehensive profiling of the gut-brain axis was performed using 16S ribosomal RNA sequencing and untargeted and targeted metabolomic analyses. The causal role of the gut microbiota was further validated using fecal microbiota transplantation (FMT). RESULTS: WR_HL, CR_HL, and JCR_HL improved ADHD-like behaviors and neurotransmission dysfunction, with JCR_HL exhibiting superior intervention effects compared to WR_HL and CR_HL. These therapeutic effects are mediated through multiple pathways, including the restoration of gut microbial homeostasis, attenuation of inflammatory cascades, and repair of compromised intestinal and blood-brain barrier. The intervention also corrected systemic metabolic imbalances by specifically addressing the abnormalities in amino acid metabolism, neurotransmitter regulation, and short-chain fatty acid production. FMT experiments further confirmed the critical role of microbial modulation in mediating the behavioral and microbial regulatory effects of XRHLP. CONCLUSION: In summary, XRHLP exerts anti-ADHD effects by improving the microbiota-gut-brain axis and correcting amino acid metabolic disorders, providing new insights into the molecular mechanisms by which traditional Chinese medicine influences ADHD and offers potential avenues for drug development.
引用
- You L, Peng H, Liu J, et al. Xiaoer Huanglong pellets remodels the periphery microenvironment to improve attention deficit hyperactivity disorder based on the microbiota-gut-brain axis. Phytomedicine. 2025. PMID: 40554893. doi:10.1016/j.phymed.2025.157007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。